Rhumbline Advisers Inventiva S.A. Transaction History
Rhumbline Advisers
- $121 Billion
- Q3 2025
A detailed history of Rhumbline Advisers transactions in Inventiva S.A. stock. As of the latest transaction made, Rhumbline Advisers holds 150 shares of IVA stock, worth $594. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150Holding current value
$594% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IVA
# of Institutions
17Shares Held
5.11MCall Options Held
0Put Options Held
0-
Yiheng Capital Management, L.P. San Francisco, CA2.64MShares$10.5 Million3.98% of portfolio
-
Nea Management Company, LLC Timonium, MD1.46MShares$5.79 Million0.52% of portfolio
-
Bvf Inc San Francisco, CA686KShares$2.72 Million0.21% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny112KShares$443,6380.0% of portfolio
-
Commonwealth Equity Services, LLC64.9KShares$256,8330.0% of portfolio
About Inventiva S.A.
- Ticker IVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,134,200
- Market Cap $167M
- Description
- Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company als...